Davern Capital Partners as of June 30, 2026
Portfolio Holdings for Davern Capital Partners
Davern Capital Partners holds 15 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biontech Se Sponsored Ads (BNTX) | 12.0 | $70M | 755k | 93.05 | |
| Roivant Sciences SHS (ROIV) | 11.7 | $68M | 1.9M | 35.39 | |
| Royalty Pharma Shs Class A (RPRX) | 11.0 | $65M | 1.2M | 56.07 | |
| Ionis Pharmaceuticals (IONS) | 10.8 | $63M | 799k | 79.29 | |
| Insmed Com Par $.01 (INSM) | 10.2 | $60M | 560k | 106.62 | |
| Regeneron Pharmaceuticals (REGN) | 9.8 | $58M | 93k | 623.54 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 5.9 | $34M | 1.2M | 28.88 | |
| Alnylam Pharmaceuticals (ALNY) | 5.8 | $34M | 113k | 301.03 | |
| Natera (NTRA) | 5.5 | $32M | 119k | 271.45 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 4.1 | $24M | 446k | 53.67 | |
| Mineralys Therapeutics (MLYS) | 4.0 | $23M | 859k | 26.98 | |
| Vera Therapeutics Cl A (VERA) | 3.6 | $21M | 499k | 42.91 | |
| Generate Biomedicines Com Shs (GENB) | 2.4 | $14M | 825k | 16.87 | |
| Procept Biorobotics Corp (PRCT) | 1.8 | $11M | 465k | 22.58 | |
| Avalo Therapeutics Com New (AVTX) | 1.5 | $8.7M | 469k | 18.48 |
